BENITEC BIOPHARMA INC.
3940 TRUST WAY
HAYWARD, CALIFORNIA 94545
March 1, 2024
VIA EDGAR
Doris Stacey Gama
Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549
| Re: | Benitec Biopharma Inc. |
Registration Statement on Form S-3 (File No. 333-277310)
Dear Ms. Gama:
Pursuant to Rule 461 of the Securities Act of 1933, as amended, Benitec Biopharma Inc. hereby requests acceleration of the effective date of the above-referenced Registration Statement on Form S-3 (File No. 333-277310) so that it may become effective at 4:00 p.m. Eastern Time on March 5, 2024, or as soon thereafter as practicable.
| Very truly yours, | ||||
| BENITEC BIOPHARMA INC. | ||||
| By: | /s/ Dr. Jerel Banks | |||
| Name: | Dr. Jerel Banks | |||
| Title: | Chief Executive Officer | |||
| cc: | Louis Rambo, Proskauer Rose LLP |